HPV Beyond Cervical Cancer: A Growing Risk for Men
For decades, the human papillomavirus (HPV) has been largely associated with cervical cancer in women. However, a growing body of evidence, and increasingly, personal stories like that of Anthony Perriam, a father from Cardiff, Wales, are highlighting a critical and often overlooked reality: HPV poses a significant and rising cancer risk for men. Perriam’s recent experience – narrowly avoiding the loss of his tongue due to HPV-related cancer – serves as a stark warning and a call for greater awareness among men about this preventable disease. The Centers for Disease Control and Prevention (CDC) reports that HPV can cause several types of cancer in both men and women, and vaccination is a key preventative measure.
Perriam initially noticed a small lump under his jaw. What followed was a diagnosis of head and neck cancer linked directly to HPV infection. “I only ever heard of HPV in relation to cervical cancer. I had no idea it could cause cancers like this, especially in men,” he explained, according to reporting from the BBC. His case underscores a dangerous gap in public understanding about the virus and its potential consequences. He considers himself fortunate to still be able to eat and speak, but acknowledges that a delayed diagnosis could have had devastating results.
Understanding HPV and its Spread
HPV is a remarkably common virus, affecting the skin and mucous membranes. The CDC notes that most people will contract an HPV infection at some point in their lives, and in the vast majority of cases, the body’s immune system will clear the virus naturally. However, certain high-risk HPV types can persist and lead to the development of cancers and genital warts. Transmission typically occurs through skin-to-skin contact, most often during sexual activity. It’s important to understand that HPV is not solely a sexually transmitted infection; it can also be spread through other forms of direct contact.
Although the body often eliminates the virus, persistent infections with high-risk HPV types are the primary cause of several cancers. The National Institutes of Health (NIH) explains that it can grab years, even decades, for cancer to develop after initial HPV infection. This long latency period is one reason why awareness and early detection are so crucial. Individuals with weakened immune systems, such as those living with HIV/AIDS, may have a harder time clearing the virus and are at increased risk of developing HPV-related health problems.
Cancers Linked to HPV in Men
The types of cancers linked to HPV in men are becoming increasingly prevalent. According to data from the CDC, as of 2022, HPV was responsible for approximately 12,500 cases of oropharyngeal cancer (cancers of the back of the throat, including the base of the tongue and tonsils) in men annually. Other HPV-related cancers in men include anal cancer (around 2,200 cases per year) and penile cancer (approximately 900 cases per year).
Oropharyngeal cancer, in particular, has seen a dramatic rise in recent years, largely attributed to changes in sexual behavior and increased oral sexual contact. The Mayo Clinic explains that HPV-positive oropharyngeal cancers tend to occur in younger men and respond differently to treatment than those caused by other factors, such as tobacco and alcohol use. This difference in treatment response highlights the importance of identifying HPV as the causative agent.
The Role of Vaccination
The most effective way to prevent HPV-related cancers is vaccination. The HPV vaccine, initially recommended for young girls to prevent cervical cancer, is now also strongly recommended for boys and young men. The CDC states that vaccination can prevent more than 90% of cancers caused by HPV. The vaccine works best when administered before the onset of sexual activity, ideally between the ages of 11 and 12, but it can be given up to age 26.
In December 2023, the FDA approved the use of the HPV vaccine Gardasil 9 for adults aged 27 through 45 years. This expanded approval was based on fresh data demonstrating the vaccine’s effectiveness in preventing HPV-related cancers in this age group. However, the CDC notes that vaccination is less effective in individuals who have already been exposed to HPV. Early vaccination remains the most impactful strategy.
Symptoms and Detection
One of the challenges in addressing HPV-related cancers in men is the lack of routine screening. Unlike women, who undergo regular Pap tests to detect cervical abnormalities, there is no standard screening test for HPV-related cancers in men. This means that men often don’t realize they are infected until symptoms develop, which can be a sign of advanced disease.
Symptoms of HPV-related cancers can vary depending on the location of the cancer. Symptoms of oropharyngeal cancer may include a sore throat that doesn’t heal, difficulty swallowing, ear pain, and a lump in the neck. Symptoms of anal cancer may include bleeding from the anus, pain, and itching. Penile cancer may present as a lump, sore, or ulcer on the penis. Any persistent or unexplained symptoms should be promptly evaluated by a healthcare professional.
Looking Ahead: Increasing Awareness and Improving Prevention
Anthony Perriam’s story is a powerful reminder that HPV is not just a women’s health issue. Raising awareness among men about the risks of HPV and the benefits of vaccination is crucial to reducing the incidence of HPV-related cancers. Increased access to vaccination, coupled with improved screening and early detection efforts, can save lives.
The CDC provides comprehensive information about HPV, including vaccination recommendations, cancer prevention strategies, and resources for healthcare providers. Open communication between patients and their doctors is also essential. Men should discuss their HPV risk factors with their healthcare providers and ask about vaccination if they are eligible.
The expansion of HPV vaccine eligibility to adults aged 27-45 represents a significant step forward in cancer prevention. However, continued research is needed to better understand the long-term effectiveness of the vaccine and to develop new strategies for preventing and treating HPV-related cancers. The future of HPV prevention relies on a multi-faceted approach that includes vaccination, awareness, and early detection.
The next step in addressing this public health concern will be monitoring the impact of the expanded vaccine eligibility and continuing to educate the public about the risks of HPV. For more information on HPV and cancer prevention, please visit the CDC website: https://www.cdc.gov/hpv/index.html. Share your thoughts and experiences in the comments below.